SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-018964
Filing Date
2024-06-03
Accepted
2024-06-03 09:00:24
Documents
18
Period of Report
2024-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K omer20240531_8k.htm   iXBRL 8-K 51679
2 EXHIBIT 10.1 ex_682752.htm EX-10.1 926502
3 EXHIBIT 10.2 ex_682687.htm EX-10.2 269188
4 EXHIBIT 99.1 ex_682739.htm EX-99.1 18117
9 pic1.jpg GRAPHIC 6407
  Complete submission text file 0001437749-24-018964.txt   1678811

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA omer-20240603.xsd EX-101.SCH 3408
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20240603_def.xml EX-101.DEF 11423
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20240603_lab.xml EX-101.LAB 15309
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20240603_pre.xml EX-101.PRE 11583
21 EXTRACTED XBRL INSTANCE DOCUMENT omer20240531_8k_htm.xml XML 2824
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 241012150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)